Envista Shares Rally 37.1% in a Year, Outpacing Industry and Market

EarningsCorporate Action

โดย Zacks Investment Research·Read original

Summary · why it matters

Envista Holdings shares have surged 37.1% over the past 12 months, far outpacing the dental products industry's 30.3% decline and the S&P 500's 28.2% gain. The company's first-quarter 2026 results showed 8.4% core growth in Specialty Products & Technologies and 11.5% in Equipment and Consumables, driven by new product launches including the Nobel S Series implants, Spark clear aligners in Japan, and AI-enhanced DEXIS software. Gross margin expanded 100 basis points and adjusted EBITDA margin rose 120 basis points, even as the company offset an $11 million increase in tariff costs. Envista also acquired Versah for about $54.7 million, adding the Densah Burs osseodensification system to its implant portfolio. The Zacks Consensus Estimate projects 2026 earnings per share of $1.42, up 19.3% year over year, on revenue of $2.86 billion.

Envista Holdings Corp ▲